Want to see HK:8143 full AI Analyst Report?

Good Fellow Healthcare Holdings Limited (8143) Ratios

0 Followers

Good Fellow Healthcare Holdings Limited Ratios

HK:8143's free cash flow for Q3 2025 was HK$0.24. For the 2025 fiscal year, HK:8143's free cash flow was decreased by HK$ and operating cash flow was HK$-0.38. See a summary of the company’s cash flow.

Ratios	TTM	Mar 25	Mar 24	Mar 23	Mar 22
Liquidity Ratios
Current Ratio	―	1.38	0.52	0.34	1.33
Quick Ratio	―	1.38	0.52	0.30	1.25
Cash Ratio	―	0.76	0.23	0.14	0.87
Solvency Ratio	―	-0.71	-0.07	-0.40	0.05
Operating Cash Flow Ratio	―	0.00	0.16	-0.03	-0.06
Short-Term Operating Cash Flow Coverage	―	0.00	0.25	-0.12	-0.53
Net Current Asset Value	HK$ ―	HK$ 6.66M	HK$ -8.03M	HK$ -19.03M	HK$ 4.74M
Leverage Ratios
Debt-to-Assets Ratio	―	0.02	1.07	0.42	0.11
Debt-to-Equity Ratio	―	0.06	-1.62	2.81	0.20
Debt-to-Capital Ratio	―	0.05	2.62	0.74	0.17
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.00	0.00
Financial Leverage Ratio	―	3.13	-1.51	6.69	1.88
Debt Service Coverage Ratio	―	-21.62	0.17	-1.51	0.62
Interest Coverage Ratio	―	-86.63	-37.78	-52.06	-12.65
Debt to Market Cap	―	0.02	1.30	0.06	0.02
Interest Debt Per Share	―	0.01	0.37	0.02	<0.01
Net Debt to EBITDA	―	0.99	3.60	-0.85	-7.22
Profitability Margins
Gross Profit Margin	―	52.85%	51.92%	47.93%	48.79%
EBIT Margin	―	-65.64%	-44.53%	-41.16%	-9.46%
EBITDA Margin	―	-65.21%	11.54%	-25.97%	3.30%
Operating Profit Margin	―	-65.64%	-44.53%	-41.16%	-9.46%
Pretax Profit Margin	―	-62.44%	-45.71%	-41.95%	-10.21%
Net Profit Margin	―	-62.43%	-62.82%	-43.91%	-10.62%
Continuous Operations Profit Margin	―	-62.44%	-45.64%	-44.63%	-10.26%
Net Income Per EBT	―	99.98%	137.45%	104.69%	104.07%
EBT Per EBIT	―	95.12%	102.65%	101.92%	107.91%
Return on Assets (ROA)	―	-49.24%	-103.00%	-58.70%	-14.10%
Return on Equity (ROE)	―	-154.03%	155.58%	-392.70%	-26.50%
Return on Capital Employed (ROCE)	―	-167.04%	106.26%	-454.15%	-24.51%
Return on Invested Capital (ROIC)	―	-157.97%	-189.91%	-117.60%	-19.86%
Return on Tangible Assets	―	-49.24%	-103.00%	-58.70%	-14.10%
Earnings Yield	―	-56.87%	-124.77%	-13.80%	-5.80%
Efficiency Ratios
Receivables Turnover	―	2.03	3.65	36.55	8.02
Payables Turnover	―	14.53	27.10	15.97	16.59
Inventory Turnover	―	0.00	0.00	19.09	17.03
Fixed Asset Turnover	―	16.40	12.66	1.93	3.78
Asset Turnover	―	0.79	1.64	1.34	1.33
Working Capital Turnover Ratio	―	-29.33	-1.29	-7.66	6.41
Cash Conversion Cycle	―	154.68	86.48	6.26	44.91
Days of Sales Outstanding	―	179.81	99.94	9.99	45.49
Days of Inventory Outstanding	―	0.00	0.00	19.12	21.43
Days of Payables Outstanding	―	25.12	13.47	22.85	22.01
Operating Cycle	―	179.81	99.94	29.11	66.91
Cash Flow Ratios
Operating Cash Flow Per Share	―	0.00	0.09	>-0.01	>-0.01
Free Cash Flow Per Share	―	0.00	0.09	-0.03	>-0.01
CapEx Per Share	―	0.00	<0.01	0.03	<0.01
Free Cash Flow to Operating Cash Flow	―	0.00	0.98	17.97	2.91
Dividend Paid and CapEx Coverage Ratio	―	0.00	63.95	-0.06	-0.52
Capital Expenditure Coverage Ratio	―	0.00	63.95	-0.06	-0.52
Operating Cash Flow Coverage Ratio	―	0.00	0.25	-0.07	-0.29
Operating Cash Flow to Sales Ratio	―	0.00	0.16	-0.02	-0.02
Free Cash Flow Yield	―	0.00%	31.80%	-12.37%	-3.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-1.76	-0.80	-7.25	-17.25
Price-to-Sales (P/S) Ratio	―	1.10	0.50	3.18	1.83
Price-to-Book (P/B) Ratio	―	2.71	-1.25	28.46	4.57
Price-to-Free Cash Flow (P/FCF) Ratio	―	0.00	3.14	-8.08	-26.41
Price-to-Operating Cash Flow Ratio	―	0.00	3.10	-145.20	-76.86
Price-to-Earnings Growth (PEG) Ratio	―	0.16	0.01	-0.04	-0.13
Price-to-Fair Value	―	2.71	-1.25	28.46	4.57
Enterprise Value Multiple	―	-0.69	7.96	-13.10	48.31
Enterprise Value	―	9.08M	14.82M	132.59M	88.27M
EV to EBITDA	―	-0.69	7.96	-13.10	48.31
EV to Sales	―	0.45	0.92	3.40	1.59
EV to Free Cash Flow	―	0.00	5.74	-8.64	-22.98
EV to Operating Cash Flow	―	0.00	5.65	-155.26	-66.87
Tangible Book Value Per Share	―	0.20	-0.23	<0.01	0.03
Shareholders’ Equity Per Share	―	0.20	-0.22	<0.01	0.04
Tax and Other Ratios
Effective Tax Rate	―	0.00	<0.01	-0.06	>-0.01
Revenue Per Share	―	0.50	0.55	0.07	0.10
Net Income Per Share	―	-0.31	-0.35	-0.03	-0.01
Tax Burden	―	1.00	1.37	1.05	1.04
Interest Burden	―	0.95	1.03	1.02	1.08
Research & Development to Revenue	―	0.00	0.00	0.00	0.00
SG&A to Revenue	―	0.85	1.13	0.52	0.43
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	0.00	-0.36	0.05	0.23

Currency in HKD